• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后子宫肌瘤的萎缩:一项对97例患者进行为期10年每年监测的回顾性研究。

Postmenopausal Shrinkage of Uterine Myomas: A Retrospective Study of 97 Cases Monitored Annually for 10 Years.

作者信息

Oue Kenta, Ichimura Tomoyuki, Murakami Makoto, Matsuda Makiko, Kawamura Naoki, Fukuda Takeshi, Sumi Toshiyuki

机构信息

Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka, JPN.

Gynecology, Osaka City General Hospital, Osaka, JPN.

出版信息

Cureus. 2024 Oct 1;16(10):e70656. doi: 10.7759/cureus.70656. eCollection 2024 Oct.

DOI:10.7759/cureus.70656
PMID:39359333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11445194/
Abstract

Introduction and aim Both patients and gynecologists are concerned about how much and how quickly myomas shrink after menopause. This study aimed to elucidate clinical findings that may be associated with postmenopausal shrinkage of uterine myomas. Materials and methods This study included 97 patients who underwent menopause by August 2012, had myoma nodules with the longest diameter between 50 mm and 160 mm, and visited our specialized myoma clinic annually for at least 10 years after menopause. They underwent transabdominal ultrasonography at least once per year. An experienced gynecologist measured the longest diameter of myoma nodules with a maximum diameter between 50 mm and 160 mm. The shrinkage rate of myoma diameters after menopause compared to premenopausal diameters was calculated each year for 10 years. The shrinkage rate of the longest diameter of the largest nodule 10 years after menopause (10-year shrinkage rate) and its relationship with clinical findings (the age at menopause, parity, body mass index {BMI}, number of nodules, MRI findings on T2-weighted image, location of the nodule, and longest diameter of the largest nodule before menopause) were analyzed. Additionally, we examined annual changes in shrinkage rate of myomas over a 10-year period after menopause (annual trend), and the relationship between annual trends and factors such as BMI and the number of nodules. Results In this examination of 10-year shrinkage rate, the group with a BMI of less than 25 showed a significantly greater shrinkage rate compared to the group with a BMI of 25 or more (25.0% vs 15.7%, p=0.023). Additionally, the group with a single nodule showed a significantly greater 10-year shrinkage rate compared to the group with four or more nodules (26.3% vs 15.2%, p=0.036). For annual trends, the rate of change in the first two years after menopause was significantly faster compared to the trend from the third to the 10th year (difference in slope: 3.888 points per year, p<0.001). When divided into two groups based on the number of nodules (one or two nodules group and three or more nodules group), the group with one or two nodules showed a significant difference in the shrinkage rate between up to two years after menopause and from the period from the third to the 10th year (difference in slope: 4.590 points per year, p<0.001). However, for the group with three or more nodules, there was no significant difference in the annual trend between the first two years after menopause and the rate from the third to the 10th year (difference in slope: 1.626 points per year, p=0.107). Conclusion BMI and the number of myoma nodules were significantly related to the 10-year shrinkage rate. Although myomas shrank significantly faster within the first two years after menopause compared to the later period, the early annual trend did not differ significantly from the trend in the later period when there were multiple nodules with a maximum diameter of 50 mm or more.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/686e83bdedc2/cureus-0016-00000070656-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/d3f9cc9421f0/cureus-0016-00000070656-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/3e9414c13886/cureus-0016-00000070656-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/ba526cc88159/cureus-0016-00000070656-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/2b7e3addf040/cureus-0016-00000070656-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/362db8813ba9/cureus-0016-00000070656-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/686e83bdedc2/cureus-0016-00000070656-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/d3f9cc9421f0/cureus-0016-00000070656-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/3e9414c13886/cureus-0016-00000070656-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/ba526cc88159/cureus-0016-00000070656-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/2b7e3addf040/cureus-0016-00000070656-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/362db8813ba9/cureus-0016-00000070656-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef5/11445194/686e83bdedc2/cureus-0016-00000070656-i06.jpg
摘要

引言与目的 患者和妇科医生都关心绝经后肌瘤缩小的程度和速度。本研究旨在阐明可能与绝经后子宫肌瘤缩小相关的临床发现。

材料与方法 本研究纳入了截至2012年8月已绝经、肌瘤结节最长直径在50毫米至160毫米之间、绝经后至少10年每年到我们的专业肌瘤诊所就诊的97例患者。她们每年至少接受一次经腹超声检查。由一位经验丰富的妇科医生测量最长直径在50毫米至160毫米之间的肌瘤结节的最长直径。计算绝经后10年每年肌瘤直径相对于绝经前直径的缩小率。分析绝经后10年最大结节最长直径的缩小率(10年缩小率)及其与临床发现(绝经年龄、产次、体重指数{BMI}、结节数量、T2加权图像的MRI表现、结节位置以及绝经前最大结节的最长直径)之间的关系。此外,我们研究了绝经后10年期间肌瘤缩小率的年度变化(年度趋势),以及年度趋势与BMI和结节数量等因素之间的关系。

结果 在本次10年缩小率检查中,BMI小于25的组与BMI为25或更高的组相比,缩小率显著更高(25.0%对15.7%,p = 0.023)。此外,单个结节组与四个或更多结节组相比,10年缩小率显著更高(26.3%对15.2%,p = 0.036)。对于年度趋势,绝经后前两年的变化率与第三年至第十年的趋势相比显著更快(斜率差异:每年3.888个百分点,p<0.001)。根据结节数量分为两组(一或两个结节组和三个或更多结节组)时,一或两个结节组在绝经后两年内与第三年至第十年期间的缩小率存在显著差异(斜率差异:每年4.590个百分点,p<0.001)。然而,对于三个或更多结节组,绝经后前两年与第三年至第十年的年度趋势之间没有显著差异(斜率差异:每年1.626个百分点,p = 0.107)。

结论 BMI和肌瘤结节数量与10年缩小率显著相关。尽管绝经后前两年肌瘤缩小明显快于后期,但当最大直径为50毫米或更大的结节数量较多时,早期年度趋势与后期趋势没有显著差异。

相似文献

1
Postmenopausal Shrinkage of Uterine Myomas: A Retrospective Study of 97 Cases Monitored Annually for 10 Years.绝经后子宫肌瘤的萎缩:一项对97例患者进行为期10年每年监测的回顾性研究。
Cureus. 2024 Oct 1;16(10):e70656. doi: 10.7759/cureus.70656. eCollection 2024 Oct.
2
Relationship of myoma cell size and menopausal status in small uterine leiomyomas.小子宫平滑肌瘤中肌瘤细胞大小与绝经状态的关系
Arch Pathol Lab Med. 2000 Oct;124(10):1448-53. doi: 10.5858/2000-124-1448-ROMCSA.
3
Accuracy of the Measurement of Uterine Leiomyoma by Transabdominal Ultrasonography.经腹超声检查测量子宫平滑肌瘤的准确性
Cureus. 2024 Aug 30;16(8):e68193. doi: 10.7759/cureus.68193. eCollection 2024 Aug.
4
Sonographic Monitoring of Growth of Uterine Myomas in Untreated Women and Respective Influence Factors.未治疗女性子宫肌瘤生长的超声监测及相关影响因素
Geburtshilfe Frauenheilkd. 2023 Apr 5;83(4):446-452. doi: 10.1055/a-1996-2980. eCollection 2023 Apr.
5
The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.妇产科医生-介入放射科医生关系对子宫肌瘤患者治疗方式选择的影响。
J Minim Invasive Gynecol. 2010 Mar-Apr;17(2):214-21. doi: 10.1016/j.jmig.2009.12.015.
6
Uterine fibroid embolization: nonsurgical treatment for symptomatic fibroids.子宫肌瘤栓塞术:有症状子宫肌瘤的非手术治疗方法
J Am Coll Surg. 2001 Jan;192(1):95-105. doi: 10.1016/s1072-7515(00)00738-9.
7
Radiofrequency Thermal Ablation for Uterine Myomas: Long-term Clinical Outcomes and Reinterventions.子宫肌瘤的射频热消融:长期临床结局及再次干预
J Minim Invasive Gynecol. 2017 Sep-Oct;24(6):1020-1028. doi: 10.1016/j.jmig.2017.05.021. Epub 2017 Jun 27.
8
Myoma-associated pain frequency and intensity: a retrospective evaluation of 1548 myoma patients.子宫肌瘤相关疼痛的频率和强度:对1548例子宫肌瘤患者的回顾性评估
Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:137-40. doi: 10.1016/j.ejogrb.2016.02.026. Epub 2016 Feb 21.
9
Ratio of directly necrotized volume to total volume of a submucosal myoma predicts shrinkage after microwave endometrial ablation.黏膜下肌瘤直接坏死体积与总体积的比值可预测微波子宫内膜消融术后的肌瘤缩小情况。
J Obstet Gynaecol Res. 2009 Aug;35(4):717-24. doi: 10.1111/j.1447-0756.2009.01018.x.
10
Long term effects of Tibolone on postmenopausal women with uterine myomas.替勃龙对绝经后子宫肌瘤妇女的长期影响。
Maturitas. 2001 Oct 31;40(1):95-9. doi: 10.1016/s0378-5122(01)00234-1.

本文引用的文献

1
Accuracy of the Measurement of Uterine Leiomyoma by Transabdominal Ultrasonography.经腹超声检查测量子宫平滑肌瘤的准确性
Cureus. 2024 Aug 30;16(8):e68193. doi: 10.7759/cureus.68193. eCollection 2024 Aug.
2
Review of uterine fibroids: imaging of typical and atypical features, variants, and mimics with emphasis on workup and FIGO classification.子宫肌瘤的影像学表现:典型和非典型特征、变异型及类似病变的影像表现,重点介绍检查方法和 FIGO 分类。
Abdom Radiol (NY). 2022 Jul;47(7):2468-2485. doi: 10.1007/s00261-022-03545-x. Epub 2022 May 13.
3
Prediction of the shrinking rate of uterine leiomyoma nodules using needle biopsy specimens.
利用针吸活检标本预测子宫肌瘤结节的缩小率。
Fertil Steril. 2012 Aug;98(2):440-3. doi: 10.1016/j.fertnstert.2012.05.013. Epub 2012 Jun 29.
4
Uterine artery embolization in 101 cases of uterine fibroids: do size, location, and number of fibroids affect therapeutic success and complications?101例子宫肌瘤的子宫动脉栓塞术:肌瘤的大小、位置和数量是否会影响治疗效果及并发症?
Cardiovasc Intervent Radiol. 2008 May-Jun;31(3):521-6. doi: 10.1007/s00270-007-9288-y. Epub 2008 Jan 25.
5
Analysis of prognostic factors for patients with leiomyoma treated with uterine arterial embolization.子宫动脉栓塞术治疗平滑肌瘤患者的预后因素分析。
Am J Obstet Gynecol. 2008 Mar;198(3):270.e1-6. doi: 10.1016/j.ajog.2007.09.026. Epub 2007 Nov 12.
6
Uterine myomas: management.子宫肌瘤:管理
Fertil Steril. 2007 Aug;88(2):255-71. doi: 10.1016/j.fertnstert.2007.06.044. Epub 2007 Jul 20.
7
Molecular links between obesity and breast cancer.肥胖与乳腺癌之间的分子联系。
Endocr Relat Cancer. 2006 Jun;13(2):279-92. doi: 10.1677/erc.1.00729.
8
Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.体重指数、循环性甾体激素水平、胰岛素样生长因子-I及胰岛素样生长因子结合蛋白-3:一项针对健康女性的横断面研究
Eur J Endocrinol. 2004 Feb;150(2):161-71. doi: 10.1530/eje.0.1500161.
9
Relationship of myoma cell size and menopausal status in small uterine leiomyomas.小子宫平滑肌瘤中肌瘤细胞大小与绝经状态的关系
Arch Pathol Lab Med. 2000 Oct;124(10):1448-53. doi: 10.5858/2000-124-1448-ROMCSA.
10
Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue.GnRH类似物治疗前磁共振成像对子宫平滑肌瘤组织病理学特征和增殖活性的预测:T2加权图像与GnRH类似物疗效的相关性
J Obstet Gynaecol (Tokyo 1995). 1995 Apr;21(2):107-17. doi: 10.1111/j.1447-0756.1995.tb01083.x.